Skip to content

Auriculotherapy effects in the treatment of nausea and vomiting in pregnant women

Auriculotherapy effects in the treatment of nausea and vomiting in pregnant women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7gshm23
Enrollment
Unknown
Registered
2021-02-10
Start date
2020-08-17
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea, Vomiting, Pregnancy.

Interventions

There will be two groups of pregnant women: intervention group with 28 women and control group with 28 women, totalizing 56 participants in the study. Participants will be informed about the research
the auriculotherapy session or the placebo will be performed according to the table already mentioned, prepared by third parties, not involved in the study. In the office, the pregnant woman will be i
with a dry ear, mustard seeds will be applied, previously packed in an auriculotherapy plate, covered with beige microporous tape. The researcher was trained in Auriculotherapy in September 2019 with
E02.190.204
E02.190.044.133

Sponsors

Universidade Federaldo Ceará
Lead Sponsor
Universidade Federaldo Ceará
Collaborator

Eligibility

Sex/Gender
Female
Age
16 Years to 44 Years

Inclusion criteria

Inclusion criteria: Among the pregnant womenat 13 weeks or less of gestational age, the ones with complaints of nausea and/or vomiting, that are not in use of antiemetic drugs, that are characterized as low risk pregnancy and have availability for return in 7 days will be assessed.

Exclusion criteria

Exclusion criteria: Use of antiemetics, diagnosed mental disease, speach or hearing difficulties that might make it impossible to fill the questionary or to conduct the interview, dermatologic lesion on auriculotherapy point of treatment and allergy to the intervetion material.

Design outcomes

Primary

MeasureTime frame
The assessed primary outcome is the reduction of nausea and vomiting in at least 50% after intervention, it will be assesed with the Rhodes Index for Nausea, Vomiting and Retching.

Secondary

MeasureTime frame
Possible adverse effects will be evaluated as secondary outcome, they will be measured from their incidence; adverse effects may be: pain in treatment points, pruritus in treatment points, temperature increase on a specific auricular point.

Countries

Brazil

Contacts

Public ContactNathaly;Priscila Moraes Fróes;Aquino

Universidade Federaldo Ceará;

nathaly.bmf@hotmail.com;priscilapetenf@gmail.com8597104959;+558599805428

Outcome results

None listed

Source: REBEC (via WHO ICTRP)